Reply to the letter by Jeng et al. 'Discrepant range of sPD-1 in different studies of Chronic hepatitis B'

J Viral Hepat. 2019 Jul;26(7):931-932. doi: 10.1111/jvh.13118. Epub 2019 Jun 19.

Authors

Liang Zhou^{1

2}, Xiaoyan Li¹, Xiaohui Huang³, Lubiao Chen¹, Lin Gu³, Yuehua Huang^{1

3}

Affiliations

¹ Department of Infectious Disease, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
² Department of Critical Care Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
³ Guangdong Provincial Key Laboratory of Liver Research, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

PMID: 31054165
DOI: 10.1111/jvh.13118

No abstract available

Keywords: anti-viral treatment; hepatitis B surface antigen; hepatitis B virus.

Publication types

Letter
Comment

MeSH terms

Carcinoma, Hepatocellular*
Fibrosis
Hepatitis B virus
Hepatitis B, Chronic*
Humans
Liver Neoplasms*